Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 8, 2010, Pages 1490-1498

  Kitajima, Kazuhiro ^a,b   Suzuki, Kayo ^a   Nakamoto, Yuji ^c   Onishi, Yumiko ^b   Sakamoto, Setsu ^b   Senda, Michio ^a   Kita, Masato ^d   Sugimura, Kazuro ^b  

^a INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Contrast enhanced CT; Non enhanced CT; PET CT; Recurrence; Uterine cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER GRADING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; MUSCLE METASTASIS; PELVIS LYMPH NODE; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RECURRENCE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; UTERINE NEOPLASMS;

EID: 77956191563     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1440-2     Document Type: Article

References (26)

1. DM Larson LJ Copeland CA Stringer DM Gershenson JM Malone Jr CL Edwards 1988 Recurrent cervical carcinoma after radical hysterectomy Gynecol Oncol 30 381 387 10.1016/0090-8258(88)90252-1 1:STN:280:DyaL1c3ntF2rsg%3D%3D 3391421
2. WP Irvin LW Rice RS Berkowitz 2002 Advances in the management of endometrial adenocarcinoma. A review J Reprod Med 47 173 190 11933681
3. T Beyer DW Townsend T Brun PE Kinahan M Charron R Roddy, et al. 2000 A combined PET/CT scanner for clinical oncology J Nucl Med 41 1369 1379 1:STN:280:DC%2BD3cvitFCguw%3D%3D 10945530
4. HH Chung H Jo WJ Kang JW Kim NH Park YS Song, et al. 2007 Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence Gynecol Oncol 104 529 534 10.1016/j.ygyno.2006.09.009 17049971
5. S Sironi M Picchio C Landoni S Galimberti M Signorelli V Bettinardi, et al. 2007 Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence Eur J Nucl Med Mol Imaging 34 472 479 10.1007/s00259-006-0251-y 10.1007/s00259-006-0251-y 17106701
6. K Kitajima K Murakami E Yamasaki S Hagiwara I Fukasawa N Inaba, et al. 2008 Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer Ann Nucl Med 22 103 109 10.1007/s12149-007-0087-y 10.1007/s12149-007-0087-y 18311534
7. JY Park EN Kim DY Kim DS Suh JH Kim YM Kim, et al. 2008 Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients Int J Gynecol Cancer 18 1332 1338 10.1111/j.1525-1438.2008.01197. x 18298562
8. HH Chung WJ Kang JW Kim NH Park YS Song JK Chung, et al. 2008 The clinical impact of [18F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings Eur J Nucl Med Mol Imaging 35 1081 1088 10.1007/s00259-007-0687-8 10.1007/s00259-007-0687-8 18180917
9. K Kitajima K Murakami E Yamasaki Y Domeki Y Kaji K Sugimura 2008 Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer Eur Radiol 18 2040 2047 10.1007/s00330-008-0979-9 10.1007/s00330-008-0979-9 18425518
10. K Kitajima K Murakami E Yamasaki Y Domeki Y Kaji S Morita, et al. 2009 Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT Eur J Nucl Med Mol Imaging 36 362 372 10.1007/s00259-008-0956-1 10.1007/s00259-008-0956-1 18931841
11. E Mittra T El-Maghraby CA Rodriguez A Quon IR McDougall SS Gambhir, et al. 2009 Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma Eur J Nucl Med Mol Imaging 36 1952 1959 10.1007/s00259-009- 1206-x 10.1007/s00259-009-1206-x 1:CAS:528:DC%2BD1MXhsVCisb3J
12. K Kitajima K Murakami E Yamasaki Y Kaji I Fukasawa N Inaba, et al. 2008 Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT Eur J Nucl Med Mol Imaging 35 1912 1920 10.1007/s00259-008-0890-2 10.1007/s00259-008-0890-2 18682935
13. C Cohade RL Wahl 2003 Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography: clinical use, interpretation methods, diagnostic improvements Semin Nucl Med 33 228 237 10.1053/snuc.2003.127312 12931324
14. RE Coleman D Delbeke MJ Guiberteau PS Conti HD Royal JC Weinreb, et al. 2005 Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance J Nucl Med 46 1225 1239 16000293
15. NG Schaefer TF Hany C Taverna C Taverna B Seifert KD Stumpe, et al. 2004 Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG-PET and CT at staging and restaging - Do we need contrast-enhanced CT? Radiology 232 823 829 10.1148/radiol.2323030985 10.1148/radiol.2323030985 15273335
16. G Antoch LS Freudenberg T Beyer A Bockisch JF Debatin 2004 To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT J Nucl Med 45 56 65
17. AC Pfannenberg P Aschoff K Brechtel M Muller M Klein R Bares, et al. 2007 Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging Br J Radiol 80 437 445 10.1259/bjr/34082277 10.1259/bjr/34082277 1:STN:280:DC%2BD2svmtlWqtA%3D%3D 17329683
18. B Rodriguez-Vigil N Gomez-Leon I Pinilla D Hernandez-Maraver J Coya L Martin-Curto, et al. 2006 PET/CT in lymphoma: Prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT J Nucl Med 47 1643 1648 17015900
19. AC Pfannenberg P Aschoff K Brechtel M Muller R Bares F Paulsen, et al. 2007 Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer Eur J Nucl Med Mol Imaging 34 36 44 10.1007/s00259-006-0186-3 10.1007/s00259-006-0186-3 16896664
20. U Tateishi T Maeda T Morimoto M Miyake Y Arai EE Kim 2007 Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer Eur J Nucl Med Mol Imaging 34 1627 1634 10.1007/s00259-007-0455-9 17530248
21. T Morimoto U Tateishi T Maeda Y Arai Y Nakajima EE Kim 2008 Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: comparison of integrated PET/CT with or without contrast enhancement Eur J Radiol 67 508 513 10.1016/j.ejrad.2007.08.017 17904324
22. K Strobel S Heinrich U Bhure J Soyka P Veit-Haibach BC Pestalozzi, et al. 2008 Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the respectability of pancreatic cancer J Nucl Med 49 1408 1413 10.2967/jnumed.108. 051466 18703604
23. K Kitajima K Murakami E Yamasaki Y Domeki Y Kaji I Fukasawa, et al. 2008 Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast- enhanced CT and enhanced CT Eur J Nucl Med Mol Imaging 35 1439 1448 10.1007/s00259-008-0776-3 10.1007/s00259-008-0776-3 18418592
24. JD Soyka P Veit-Haibach K Strobel S Breitenstein A Tschopp KA Mende, et al. 2008 Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice? J Nucl Med 49 354 361 10.2967/jnumed.107.048249 18287263
25. K Kitajima K Murakami E Yamasaki Y Domeki Y Kaji M Suganuma, et al. 2009 Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: comparison with integrated FDG-PET/non-contrast- enhanced CT and enhanced CT Eur J Nucl Med Mol Imaging 36 1388 1396 10.1007/s00259-009-1081-5 10.1007/s00259-009-1081-5 19370346
26. O Mawlawi JJ Erasmus RF Munden T Pan A Knight HA Macapinlac, et al. 2006 Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation AJR Am J Roentgenol 186 308 319 10.2214/AJR.04.1740 10.2214/AJR.04.1740 16423932